Project Grant R01AG084572

Award Date 8/15/24
Completion Date 7/31/29
Dollars Obligated $703K
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Durham, NC 27710, USA
Similar Awards
This $2,147,487 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a mixed-methods study to "UNDERSTANDING AND IMPROVING PALLIATIVE CARE DELIVERY AMONG PERSONS WITH ALZHEIMER'S DISEASE AND RELATED DEMENTIAS (ADRD)". The study aims to determine the impact of "concurrent care" (delivering hospice alongside usual medical care) on patient and family outcomes for ADRD patients. Key objectives include analyzing trends in concurrent care...
PREPARING ASSISTED LIVING STAFF TO CARE FOR PERSONS WITH DEMENTIA: PALLIATIVE CARE EDUCATION IN ASSISTED LIVING FOR DEMENTIA CARE PROVIDERS - PROJECT SUMMARY/ABSTRACT MORE THAN ONE-THIRD OF THE ONE MILLION OLDER ADULTS LIVING IN ASSISTED LIVING (AL) COMMUNITIES IN THE UNITED STATES HAVE A DIAGNOSIS OF ALZHEIMER'S DISEASE OR RELATED DEMENTIA (ADRD). AN ESTIMATED 40% OF PERSONS WITH ADRD WILL DIE THERE WITH AN AVERAGE LENGTH OF AL STAY OF 2.5 YEARS, MAKING AL A COMMON SITE FOR END-OF-LIFE CARE....
This is a five-year Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) totaling $364,318. The award will support the adaptation and pilot testing of a family-centered intervention called SUCCEED-ICU to improve long-term outcomes for survivors of acute respiratory failure. The principal investigator is an assistant professor at the University of North Carolina at Chapel Hill who will receive mentorship...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $590,371 to Yale University to identify key modifiable structures and processes of specialist palliative care delivery that improve outcomes for people with advanced heart failure. The project aims to increase the reach of specialist palliative care and improve end-of-life care quality, measured by days at home, hospice enrollment, and...
This federal Project Grant award, provided by the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) program, aims to refine and pilot test a palliative care intervention called PEACE to address the unmet needs of patients receiving adoptive cellular therapy (ACT) for hematologic malignancies and their caregivers. The $293,053 grant, awarded on August 16, 2024, will support a 5-year plan to: 1) refine the PEACE intervention based on findings from an open pilot...
This federal Project Grant award of $231,000.00, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to build capacity for delivering culturally tailored palliative care services to underserved Black and Hispanic communities affected by Parkinson's disease (PD), Lewy body dementia (LBD), and related disorders. The key objectives are to: 1) strengthen...
This federal Project Grant award of $621,732 from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) will fund a hybrid effectiveness-implementation trial to evaluate a proactive identification and digital mental health intervention approach to address unmet psychosocial needs of individuals living with likely incurable cancer. The key products and services to be delivered under this 5-year grant include: 1) comprehensively assessing the...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), provides $191,792 to the University of Rochester to develop and preliminarily test an Individualized Care Plan (ICP) prototype for improving inpatient care for people living with sickle cell disease (SCD). The key objectives are to adapt an existing ICP model from the emergency department setting for use in the inpatient hospital...
This federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), provides $708,091 to Emory University to develop and test the effectiveness of the Algorithm-Enabled Patients Activated in Cancer Care through Teams (A-PACT) intervention. The A-PACT intervention aims to improve goals of care communication and reduce unwanted care utilization for patients with cancer. It uses machine learning algorithms to automatically...
The National Institute of Nursing Research (NINR) awarded a $167,407 Project Grant (CFDA 93.361 - Nursing Research) to The Trustees of the University of Pennsylvania to conduct the "Home-Based Pediatric Palliative Care Experiences for Children with Serious Illness and Families Feedback Study (EXPERIENCE-FEEDBACK)" project. This 3-year study, beginning on July 1, 2024, aims to evaluate a rapid digital feedback loop between families of children with serious illness receiving home-based...

IMPROVING NEEDS AMONG OLDER ADULTS: THE ICUCONNECT 2 PRIMARY PALLIATIVE CARE RCT - ABSTRACT MILLIONS OF OLDER ADULTS RECEIVE CARE IN INTENSIVE CARE UNITS (ICUS) ANNUALLY. HOWEVER, THE QUALITY AND ACCESSIBILITY OF ICU-BASED PALLIATIVE CARE IS HIGHLY VARIABLE ACROSS HOSPITALS AND CLINICIANS, DUE IN PART TO SPECIALISTS' LIMITED WORKFORCE AND GEOGRAPHIC INCONSISTENCY. FURTHERMORE, THERE ARE FEW EVIDENCE-BASED INTERVENTIONS DESIGNED TO HELP ICU CLINICIANS PROVIDE PRIMARY PALLIATIVE CARE THEMSELVES-AND EVEN FEWER INTERVENTIONS TESTED AMONG PARTICIPANTS WHO ADEQUATELY REFLECT THE RACIAL AND ETHNIC DIVERSITY OF THE US. TO ADDRESS THESE GAPS, WE DEVELOPED AN INNOVATIVE MOBILE APP-BASED PRIMARY PALLIATIVE CARE INTERVENTION CALLED ICUCONNECT. ICUCONNECT FACILITATES FAMILIES' AND PATIENTS' SELF-REPORT OF ACTUAL PALLIATIVE CARE NEEDS ACROSS ALL CORE DOMAINS OF PALLIATIVE CARE QUALITY, PROVIDES ICU CLINICIANS WITH A SCALABLE DIGITAL INFRASTRUCTURE FOR COORDINATING CONSISTENT AND PERSONALIZED NEEDS-TARGETED CARE, AND PROVIDES A VARIETY OF INFORMATIONAL SUPPORTS RELEVANT TO EACH USER'S ROLE. IN A RECENT SINGLE-CENTER CLUSTER RCT WITH 111 PATIENT-FAMILY MEMBER DYADS (U54 MD012530), 42% OF WHOM WERE BLACK, ICUCONNECT SIGNIFICANTLY IMPROVED UNMET NEEDS AND GOAL CONCORDANCE OF CARE COMPARED TO USUAL CARE CONTROL. WE HAVE SINCE LINGUISTICALLY AND CULTURALLY ADAPTED THE INTERVENTION TO LATIN AMERICAN SPANISH. WHAT IS NOW NEEDED IS A MULTICENTER RCT TO TEST THE INTERVENTION'S EFFICACY IN A POPULATION DIVERSE IN RACE, ETHNICITY, AND GEOGRAPHY THAT REFLECTS THE REAL-WORLD EXPERIENCE OF PATIENTS AND FAMILY MEMBERS. THEREFORE, WE PROPOSE TO TEST ICUCONNECT VS. USUAL CARE CONTROL AMONG 350 PATIENT-FAMILY MEMBER DYADS WITH ELEVATED BASELINE LEVELS OF UNMET PALLIATIVE CARE NEED IN A 4-SITE NETWORK SERVING A DIVERSE POPULATION (DUKE, MEDICAL UNIVERSITY OF SOUTH CAROLINA, UNIVERSITY OF ALABAMA AT BIRMINGHAM, COLUMBIA). THE SPECIFIC AIMS ARE TO: (1) TEST THE EFFICACY OF ICUCONNECT VS. USUAL CARE CONTROL IN IMPROVING PALLIATIVE CARE NEEDS AND OTHER PERSON-CENTERED OUTCOMES INCLUDING PSYCHOLOGICAL DISTRESS, (2) DETERMINE PARTICIPANT CHARACTERISTICS ASSOCIATED WITH A GREATER TREATMENT RESPONSE USING A HETEROGENEITY OF TREATMENT EFFECTS APPROACH, AND (3) ENSURE OFF-THE-SHELF INTERVENTION READINESS FOR IMPLEMENTATION USING A MIXED-METHODS INTEGRATION OF QUALITATIVE ANALYSIS OF SEMI-STRUCTURED TRIAL PARTICIPANT INTERVIEWS AND QUANTITATIVE RE-AIM IMPLEMENTATION FRAMEWORK-INFORMED TRIAL DATA. THIS PROJECT IS LIKELY TO MAKE A STRONG CLINICAL IMPACT BECAUSE IT FILLS NOTABLE GAPS IN THE RIGOR OF PRIOR RESEARCH, TARGETS POPULATIONS OFTEN OMITTED FROM PAST PALLIATIVE CARE TRIALS, AND TESTS AN INNOVATIVE INTERVENTION THAT COULD BE IMMEDIATELY USED IN ANY HEALTHCARE SETTING AT POPULATION SCALE, IS EASILY ADAPTABLE TO ANY LANGUAGE, LEVERAGES STRONG PRELIMINARY DATA, AND INCLUDES NEW CONCEPTS IN CARE DELIVERY AND OUTCOMES MEASUREMENT. THE LIKELIHOOD OF SUCCESS IS HIGH BECAUSE OF THE TEAM'S EXPERTISE IN CLINICAL TRIALS, CRITICAL CARE, PALLIATIVE CARE, GERIATRICS, HEALTH EQUITY, AND HEALTH TECHNOLOGY.

Posted 8/13/24, 12:00 AM